Welcome to Ebola Virus Net
Ebola Virus Net is the web resource for anyone interested in ebola. Ebola (Ebola hemorrhagic fever), is a severe, often fatal disease in humans and nonhuman primates such as monkeys, gorillas, and chimpanzees. Ebola is a rare and deadly disease caused by infection with a virus of the family Filoviridae, genus Ebolavirus. There are five identified Ebolavirus species, four of which have caused disease in humans. Ebola is found in several African countries. The first Ebola species was discovered in 1976 near the Ebola River in the Democratic Republic of the Congo. Since then, outbreaks have appeared sporadically in Africa. The largest outbreak to date was the epidemic in West Africa, which occurred from December 2013, to January 2016, with 28,646 cases and 11,323 deaths. Other outbreaks in Africa began in the Democratic Republic of the Congo in May 2017 and 2018. In July 2019, the World Health Organization declared the Congo Ebola outbreak a world health emergency.
When an infection does occur in humans, the virus can be spread to others through direct contact with the blood or body fluids of a person who is sick with Ebola, or through contact with objects that have been contaminated with the blood or body fluids of an infected person. Until recent, no vaccines were effective. In December 2016, Ebola was found to be 70–100% prevented by rVSV-ZEBOV vaccine, making it the first proven vaccine against the disease. More than 100,000 people have been vaccinated against Ebola as of 2019.
The objectives of Ebola Virus Net are to be the public and professional information resource for ebola and to serve as a network in the exchange of information and news related to ebola.
Ebola News and Headlines
- Ebola RNA persists for months in breast milk, semen of survivors - Healio
Tue, 19 Nov 2019 19:13 GMT - Study Says Conflicts In The Congo Affecting Ebola Outbreaks - Texas A&M University
Tue, 19 Nov 2019 22:17 GMT - 1st Ebola vaccine approved - ABC News
Wed, 13 Nov 2019 17:34 GMT - ‘Ebola Business’: How Mistrust Is Fueling Attacks on Health Workers in Eastern Congo - World Politics Review
Tue, 19 Nov 2019 19:28 GMT - What it takes to protect gorillas from Ebola - National Geographic
Fri, 15 Nov 2019 12:49 GMT - Media Outlets Report On Global Approval Of Ebola Vaccine, Challenges Of Ebola Prevention Efforts In DRC - Kaiser Family Foundation
Tue, 19 Nov 2019 17:14 GMT - The Ebola Vaccine Is Now Officially Here With Approval In Europe - Forbes
Mon, 11 Nov 2019 08:00 GMT - The world finally has an approved vaccine against Ebola - Ars Technica
Wed, 13 Nov 2019 00:14 GMT - At Ebola ground zero in DR Congo, new vaccine offers hope - Al Jazeera English
Thu, 14 Nov 2019 18:02 GMT - EU conditionally OKs Ebola vaccine, CDC updates antibiotic resistance figures — top stories in infectious disease - Healio
Tue, 19 Nov 2019 20:18 GMT - WHO: Biakato Mines region linked to recent Ebola cases - CIDRAP
Wed, 13 Nov 2019 22:27 GMT - USAID Funding Reaches $266 Million To Stop Ongoing Ebola Outbreak - Vax Before Travel
Sat, 09 Nov 2019 08:00 GMT - Ebola vaccine licensure is underway - WCJB
Tue, 19 Nov 2019 23:41 GMT - European commission gives green light to first Ebola vaccine - Chemistry World
Mon, 18 Nov 2019 10:04 GMT - WHO says Congo's Ebola outbreak still qualifies as a global emergency - ABC News
Mon, 21 Oct 2019 07:00 GMT
Latest Ebola Posts on ProMED-mail
- PRO/AH/EDR> Ebola update (109): Congo DR (NK, IT) cases, WHO, summaries, response, vaccine
Mon, 18 Nov 2019 18:53:50 -0500
Ebola -- DR Congo
- The General Coordinator for the Ebola Response to the Ebola Virus Disease, Prof Steve Ahuka Mundeke, accompanied by a joint team of some members of the response and the consortium (National Institute of Biomedical Research-INRB, MSF / France and the London School), met this Wed 13 Nov 2019 the Vice President of the North Kivu Provincial Assembly, the Honorable Jean-Paul Lumbulumbu, with whom they discussed the 2nd Ebola vaccine called Johnson & Johnson.
- The teacher Steve Ahuka Mundeke,